tradingkey.logo

BRIEF-Recursion Presents Phase 2 Data For REC-994 in CCM

ReutersFeb 5, 2025 11:24 PM

- Recursion Pharmaceuticals Inc RXRX.O:

  • RECURSION PRESENTS PHASE 2 DATA FOR REC-994 IN CCM IN LATE-BREAKING ORAL PRESENTATION AT THE INTERNATIONAL STROKE CONFERENCE

Source text: ID:nGNX76R7sN

Further company coverage: RXRX.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI